Do You Trust Your Contract Labs?

Are you evaluating their capabilities prior to using them?

An API facility recently received this 483 observation: 

…..Contract laboratories are not evaluated to ensure GMP compliance.

Specifically, your firm has repeatedly demonstrated that you have no assurance in the capability of your contract laboratories to perform testing that ensures compliance with established specifications and standards.  For example:

a.         API …..,  lot ….., was sent to ….. for potency testing.  The result was …..%, which is above the specification.  ….. uses a ….. method for potency testing; however they also tested lot ….. with the method, obtaining a result of ….., which confirmed the initial OOS result.  Your firm’s investigation of this OOS states that “in distrust of (….. methods of analysis), your firm sent an additional sample of lot ….. to ….. for analysis.  This result was returned within specification; however, there is no evidence to suggest that the results obtained by the first lab are invalid.  ….., lot ….., was released.

For more details on this observation as well as other observations pertaining to Active Pharmaceutical Manufacturers see Issue 1015 available today.  It features observations from API Manufacturers on our rotating page 3 topic as well as Laboratory Controls and Medical Device Manufacturing Controls.

Stay in Compliance! Subscribe today!

Stay in Compliance!

To get the most out of GMP Trends®, sign up to one of our subscription packages for valuable, up-to-date information you won't find anywhere else!

LEARN MORE
About GMP Trends

GMP TRENDS is a publication for the pharmaceutical and medical device industries, trending observations made by FDA investigators during GMP inspections throughout the world.

Available Reports
Stay in Compliance!

Sign up for free highlights and updates from GMP Trends


Report Categories
Recent Posts
Recent Comments
Archives
Categories
Meta

Become A Subscriber And Stay Ahead of the FDA

To get the most out of GMP Trends®, sign up to one of our subscription packages for valuable, up-to-date information you won't find anywhere else! Every subscription provides the most frequently cited FDA 483 observations taken from recent FDA Inspections. The non-essential information is redacted to streamline the facts in an easily readable format. Join the thousands of professionals who rely on GMP Trends® to keep them informed of the latest FDA Enforcement Trends!

SUBSCRIBE NOW